Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New antibody profiling technique to test for lung cancer

16.11.2005


American Thoracic Society journal news tips for November 2005 (second issue)



Biomedical scientists have revealed a new and promising antibody profiling technique that provides a high degree of early diagnostic accuracy for non-small cell lung cancer cases.

Their research was reported in the second issue of November 2005 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.


Li Zong, Ph.D. of the Division of Pulmonary and Critical Care Medicine, Chandler Medical Center, University of Kentucky, Lexington, along with five associates, has identified five non-small cell lung cancer-associated antibody proteins that achieved 90 percent sensitivity and 95 percent specificity in identifying cancerous versus non-cancerous patient samples.

(Sensitivity indicates the probability that results will be positive when disease is present. Specificity identifies the probability that results will be negative when disease is absent.)

According to the U.S. National Cancer Institute, 160,000 people die each year from lung cancer, making it the number one cause of cancer death in America. Smoking is the primary cause of the disease.

The authors state that presently only 25 percent of new cases of lung cancer are diagnosed at an early stage, when curative surgery is possible.

"Serum tumor markers have the potential of being incorporated into diagnostic and therapeutic practice to improve historically dismal outcomes in non-small cell lung cancer," said Dr. Zong. "Potential uses include early detection or screening, differentiation of benign from malignant disease, differentiating histologies, defining stages and responses to therapy, and defining prognosis.

"These goals have generated considerable interest in identifying predictive tumor markers," Dr. Zong continues. "Although a number of non-small cell lung cancer tumor markers are measurable and a combination of markers can enhance diagnostic value, limited sensitivity and specificity of these markers preclude their wide-spread clinical use. In context, tumor-associated antigens may expand the range of non-small cell lung cancer markers. Consistent with the knowledge that an antibody response to a single protein is unlikely to be a universal marker, we have been exploring methodology for efficiently identifying and measuring multiple tumor-associated antibodies."

From a universe of 212 candidate markers, the researchers reduced the group to the five most predictive cancer-associated antibody proteins.

"Results show that five phage markers had significant ability to distinguish patient samples from normal control subjects in the training set, said Dr. Li.

Based on their results, they hope to develop a diagnostic assay to assist in early diagnosis of lung cancer.

During development, the researchers tested the proteins associated with predominately advanced-stage lung cancer since those cells were theoretically more likely to express both high levels of and a greater variety of antibodies.

In subsequent studies, they plan to test persons who have early-stage lung cancer against matched control subjects. They hope this will help them determine the ability of antibody profiling to distinguish benign from malignant disease in a group whose potentially cancerous nodules cannot clearly be determined radiographically.

Suzy Martin | EurekAlert!
Further information:
http://www.thoracic.org

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>